Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O J Finn

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
Immunology Today|June 1, 1990
Recent advances in cellular immunology: implications for immunity to cancerM T Lotze, O J Finn
Methods in Molecular Biology (Clifton, N.J.)|May 23, 2000
Analysis of the frequency of MHC-unrestricted MUC1-specific cytotoxic T-cells in peripheral blood by limiting dilution assayJ R McKolanis, O J Finn
Biotechniques|August 1, 1992
PCR-based analysis of the T-cell receptor V beta multigene family: experimental parameters affecting its validityB L Hall, O J Finn
Advances in Immunology|January 1, 1996
Human tumor antigens are ready to flyR A Henderson, O J Finn
Human Immunology|December 1, 1989
Characteristics of a human liver allograft--derived T-cell line that exhibits suppressor activityM Emara, O J Finn, F Sanfilippo
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1995
Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucinN Doménech, R A Henderson, O J Finn
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1979
Induction, establishment in vitro, and characterization of functional, antigen-specific, carrier-primed murine T-cell lymphomasO J Finn, J Boniver, H S Kaplan
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejectionM M Soares, V Mehta, O J Finn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Suppressed T-cell receptor zeta chain expression and cytokine production in pancreatic cancer patientsJ Schmielau, M A Nalesnik, O J Finn
Immunogenetics|February 9, 2011
H-2 antigen expression: Loss in vitro, restoration in vivo, and correlation with cell-mediated cytotoxicity in a mouse lymphoma cell lineO J Finn, M Lieberman, H S Kaplan
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Immunology Today|June 1, 1990
Recent advances in cellular immunology: implications for immunity to cancerM T Lotze, O J Finn
Methods in Molecular Biology (Clifton, N.J.)|May 23, 2000
Analysis of the frequency of MHC-unrestricted MUC1-specific cytotoxic T-cells in peripheral blood by limiting dilution assayJ R McKolanis, O J Finn
Biotechniques|August 1, 1992
PCR-based analysis of the T-cell receptor V beta multigene family: experimental parameters affecting its validityB L Hall, O J Finn
Advances in Immunology|January 1, 1996
Human tumor antigens are ready to flyR A Henderson, O J Finn
Human Immunology|December 1, 1989
Characteristics of a human liver allograft--derived T-cell line that exhibits suppressor activityM Emara, O J Finn, F Sanfilippo
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1995
Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucinN Doménech, R A Henderson, O J Finn
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1979
Induction, establishment in vitro, and characterization of functional, antigen-specific, carrier-primed murine T-cell lymphomasO J Finn, J Boniver, H S Kaplan
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejectionM M Soares, V Mehta, O J Finn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Suppressed T-cell receptor zeta chain expression and cytokine production in pancreatic cancer patientsJ Schmielau, M A Nalesnik, O J Finn
Immunogenetics|February 9, 2011
H-2 antigen expression: Loss in vitro, restoration in vivo, and correlation with cell-mediated cytotoxicity in a mouse lymphoma cell lineO J Finn, M Lieberman, H S Kaplan
Pageof 10